It is estimated that about one in six people with Parkinson’s disease (PD) taking dopaminergic medication will develop an impulse control disorder (ICD) sometime during the course of their disease. Such impulsive behaviors may include uncontrolled gambling, eating, shopping, sexual activity, or punding, a purposeless activity in which a person repetitively organizes, sorts, or collects items. ICD’s are more likely to occur in older people on dopamine agonists than in younger people. Some forms of ICD can have devastating outcomes personally or within the family. Fortunately, these adverse effects of the drugs can often be managed well, especially if they are caught early, and in this regard, the family and care partners are key to recognizing and discussing them with the person with PD and the neurologist.
In this podcast, Dr. Gregory Pontone, Director of the Parkinson’s Neuropsychiatry Clinic at Johns Hopkins School of Medicine, a Parkinson’s Foundation Center of Excellence, discusses forms of ICD’s, some means to recognize them, and tools for communicating about them.
- Episode 92: Clinical Issues Behind Impulse Control Disorders (podcast)
- Advice for the Newly Diagnosed: Why Do I Keep Doing This? Impulsivity
- Fact Sheet: Impulse Control and Parkinson’s Disease
- 7 Taboo Parkinson’s Topics and How to Address Them (Blog)
About This Episode
Released: February 9, 2021
Gregory Pontone, MD, MHS
Gregory Pontone, MD, MHS is the director of the Parkinson’s disease Neuropsychiatry Clinic and an Associate Professor in the Departments of Psychiatry and Neurology at Johns Hopkins University School of Medicine in Baltimore, Maryland. After completing a medicine internship and residency training in psychiatry at Johns Hopkins, Dr. Pontone completed a two-year fellowship in geriatric psychiatry and movement disorders focusing on Parkinson’s disease through the Clinical Research Program of the Morris K. Udall Parkinson’s Disease Research Center. He also completed a fellowship in Clinical Trial Methods in Neurology sponsored by the National Institute of Neurological Disorders and Stroke. He is board certified by the American Board of Psychiatry and Neurology and has an added certification in the specialty of geriatric psychiatry. He serves on the Scientific Review Committee and as the chair of the Cognitive/Psychiatric Working Group for an international consortium of Parkinson's disease researchers, the Parkinson Study Group. He is an associate editorial board member for the American Journal of Geriatric Psychiatry.
For all of our Substantial Matters podcast episodes, visit parkinson.org/podcast.